Offer - Urjas Oil for just ₹ 1 X
Torasemide + Eplerenone is an allopathic medicine The correct dosage of Torasemide + Eplerenone depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Torasemide + Eplerenone is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Torasemide + Eplerenone is used -
Moderate
Mild
Common
Is the use of Torasemide + Eplerenone safe for pregnant women?
Pregnant women can take Torasemide + Eplerenone safely.
Is the use of Torasemide + Eplerenone safe during breastfeeding?
In the absence of any scientific study about the side effects of Torasemide + Eplerenone in breastfeeding women, information on safety of Torasemide + Eplerenone is unavailable.
What is the effect of Torasemide + Eplerenone on the Kidneys?
Torasemide + Eplerenone has very mild side effects on the kidneys.
What is the effect of Torasemide + Eplerenone on the Liver?
Side effects of Torasemide + Eplerenone rarely affect the liver.
What is the effect of Torasemide + Eplerenone on the Heart?
Very few cases of side effects of Torasemide + Eplerenone on the heart have been reported.
Torasemide + Eplerenone should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Torasemide + Eplerenone unless your doctor advises you to do so -
Is this Torasemide + Eplerenone habit forming or addictive?
Torasemide + Eplerenone is not addictive in nature.
Interaction between Food and Torasemide + Eplerenone
When consumed with certain foods, Torasemide + Eplerenone may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Torasemide + Eplerenone
Taking alcohol with Torasemide + Eplerenone can be dangerous.
Yes, an overdose of Torasemide + Eplerenone is associated with hypokalemia. It is a condition in which the blood potassium levels are too low. Symptoms are muscle fatigue, muscle cramps and feeling weak. Low potassium levels can lead to a heart problem. Therefore, if you are taking a loop diuretic, talk to your doctor about preventing hypokalemia. In addition, follow the dosing schedule prescribed by your doctor.
No, Torasemide + Eplerenone does not cause kidney damage, in fact, it helps in managing edema resulting from kidney disease, heart disease, and lung disease. In comparison to furosemide, Torasemide + Eplerenone has a longer duration of action and doesn't get accumulated in the renal failure.
Yes, an overdose of Torasemide + Eplerenone is associated with hyponatremia. Hyponatremia occurs when the concentration of sodium is extremely low in the blood. Symptoms are nausea, vomiting, headache, confusion, muscle weakness, restlessness, and loss of energy. Therefore, it is important to stick to the dosing schedule designed by your doctor and talk about the prevention of hyponatremia.
Yes, it is safe to use Torasemide + Eplerenone for as long as it is prescribed by your doctor. However, in some people, it may cause some side effects like constipation, frequent urination, ringing in the ears, and hearing loss.
Yes, Torasemide + Eplerenone may cause allergy in rare cases. The symptoms could be rash, itching, dizziness, swelling of the tongue, throat, and face, difficulty in breathing, etc. If you experience any of these symptoms, discontinue using Torasemide + Eplerenone and talk to your doctor immediately.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Inspra® (eplerenone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 561
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 508-509